BTAI
Bioxcel Therapeutics·NASDAQ
--
--(--)
--
--(--)
2.82 / 10
Underperform
Technical scoring is poor (2.82/10, Underperform). Bearish cues dominate: Long Lower Shadow and Marubozu White patterns, plus a MACD Death Cross. Only a MACD Golden Cross offers neutral upside, leaving the chart in a weak state.
Analysis Checks(0/4)
Long Lower Shadow
Score1/10
Win Rate30.56%
Hist. Signals72
Avg Return0.25%
Score1/10
Win Rate30.56%
Hist. Signals72
Avg Return0.25%
MACD Golden Cross
Score4.6/10
Win Rate50.00%
Hist. Signals12
Avg Return8.05%
Score4.6/10
Win Rate50.00%
Hist. Signals12
Avg Return8.05%
MACD Death Cross
Score4.67/10
Win Rate50.00%
Hist. Signals10
Avg Return3.41%
Score4.67/10
Win Rate50.00%
Hist. Signals10
Avg Return3.41%
Marubozu White
Score1/10
Win Rate40.00%
Hist. Signals15
Avg Return-3.36%
Score1/10
Win Rate40.00%
Hist. Signals15
Avg Return-3.36%
Long Lower Shadow
Score1/10
Win Rate30.56%
Hist. Signals72
Avg Return0.25%
Score1/10
Win Rate30.56%
Hist. Signals72
Avg Return0.25%
MACD Death Cross
Score4.67/10
Win Rate50.00%
Hist. Signals10
Avg Return3.41%
Score4.67/10
Win Rate50.00%
Hist. Signals10
Avg Return3.41%
MACD Golden Cross
Score4.6/10
Win Rate50.00%
Hist. Signals12
Avg Return8.05%
Score4.6/10
Win Rate50.00%
Hist. Signals12
Avg Return8.05%
Marubozu White
Score1/10
Win Rate40.00%
Hist. Signals15
Avg Return-3.36%
Score1/10
Win Rate40.00%
Hist. Signals15
Avg Return-3.36%
Technical Analysis of BTAI?
- BTAI presents a Underperform setup with a Technical Score of 2.82/10. Key technical indicators highlight an RSI of 34.21 and a MACD of -0.06, with the trend anchored by the 50-Day SMA at 1.61. Traders should monitor key support at 1.33 and resistance at 1.42.
